|
1
|
Wang J and Liu B: Exercise and congenital
heart disease. Adv Exp Med Biol. 1000:95–101. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Junghare SW and Desurkar V: Congenital
heart diseases and anaesthesia. Indian J Anaesth. 61:744–752. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Itani M, Matesan M, Ahuja J, Bermo M,
Habib AS, Goiney C, Krieger EV and Vesselle H: The role of
pulmonary scintigraphy in the evaluation of adults with congenital
heart disease. Semin Nucl Med. 47:660–670. 2017. View Article : Google Scholar
|
|
4
|
Suradi HS and Hijazi ZM: Adult congenital
interventions in heart failure. Interv Cardiol Clin. 6:427–443.
2017.PubMed/NCBI
|
|
5
|
Chien PS, Chiang CB, Wang Z and Chiou TJ:
MicroRNA-mediated signaling and regulation of nutrient transport
and utilization. Curr Opin Plant Biol. 39:73–79. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
de Lucia C, Komici K, Borghetti G,
Femminella GD, Bencivenga L, Cannavo A, Corbi G, Ferrara N, Houser
SR, Koch WJ and Rengo G: microRNA in cardiovascular aging and
age-related cardiovascular diseases. Front Med (Lausanne).
4:742017. View Article : Google Scholar
|
|
7
|
Stanley-Hasnain S, Hauck L, Grothe D and
Billia F: Control of cardiomyocyte proliferation through
p53/Mdm2-regulated MicroRNAs. J Heart Lung Transpl. 35(Suppl 1):
S183–S184. 2016. View Article : Google Scholar
|
|
8
|
Zhou Y, Jia WK, Jian Z, Zhao L, Liu CC,
Wang Y and Xiao YB: Downregulation of microRNA-199a-5p protects
cardiomyocytes in cyanotic congenital heart disease by attenuating
endoplasmic reticulum stress. Mol Med Rep. 16:2992–3000. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu S, Cao L, Zhu J, Kong L, Jin J, Qian
L, Zhu C, Hu X, Li M, Guo X, et al: Identification of maternal
serum MicroRNAs as novel noninvasive biomarkers for prenatal
detection of fetal congenital heart defects. Clin Chim Acta.
424:66–72. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shu YJ, Bao RF, Jiang L, Wang Z, Wang XA,
Zhang F, Liang HB, Li HF, Ye YY, Xiang SS, et al: MicroRNA-29c-5p
suppresses gallbladder carcinoma progression by directly targeting
CPEB4 and inhibiting the MAPK pathway. Cell Death Differ.
24:445–457. 2017. View Article : Google Scholar :
|
|
11
|
Han TS, Hur K, Xu G, Choi B, Okugawa Y,
Toiyama Y, Oshima H, Oshima M, Lee HJ, Kim VN, et al: MicroRNA-29c
mediates initiation of gastric carcinogenesis by directly targeting
ITGB1. Gut. 64:203–214. 2015. View Article : Google Scholar
|
|
12
|
Zhang HW, Wang EW, Li LX, Yi SH, Li LC, Xu
FL, Wang DL, Wu YZ and Nian WQ: A regulatory loop involving miR-29c
and Sp1 elevates the TGF-β1 mediated epithelial-to-mesenchymal
transition in lung cancer. Oncotarget. 7:85905–85916.
2016.PubMed/NCBI
|
|
13
|
Niu M, Gao D, Wen Q, Wei P, Pan S, Shuai
C, Ma H, Xiang J, Li Z, Fan S, et al: MiR-29c regulates the
expression of miR-34c and miR-449a by targeting DNA
methyltransferase 3a and 3b in nasopharyngeal carcinoma. BMC
Cancer. 16:2182016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Butrym A, Rybka J, Baczyńska D, Poręba R,
Kuliczkowski K and Mazur G: Clinical response to azacitidine
therapy depends on microRNA-29c (miR-29c) expression in older acute
myeloid leukemia (AML) patients. Oncotarget. 7:30250–30257. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nygren MK, Tekle C, Ingebrigtsen VA,
Mäkelä R, Krohn M, Aure MR, Nunes-Xavier CE, Perälä M, Tramm T,
Alsner J, et al: Identifying microRNAs regulating B7-H3 in breast
cancer: The clinical impact of microRNA-29c. Br J Cancer.
110:2072–2080. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang S, Zhu Y and Qiu R: Shikonin protects
H9C2 cardiomyocytes against hypoxia/reoxygenation injury through
activation of PI3K/Akt signaling pathway. Biomed Pharmacother.
104:712–717. 2018. View Article : Google Scholar
|
|
17
|
Taniyama Y, Ito M, Sato K, Kuester C, Veit
K, Tremp G, Liao R, Colucci WS, Ivashchenko Y, Walsh K and Shiojima
I: Akt3 over-expression in the heart results in progression from
adaptive to maladaptive hypertrophy. J Mol Cell Cardiol.
38:375–385. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shiojima I, Sato K, Izumiya Y, Schiekofer
S, Ito M, Liao R, Colucci WS and Walsh K: Disruption of coordinated
cardiac hypertrophy and angiogenesis contributes to the transition
to heart failure. J Clin Invest. 115:2108–2118. 2005. View Article : Google Scholar :
|
|
19
|
Yoshioka K, Yoshida K, Cui H, Wakayama T,
Takuwa N, Okamoto Y, Du W, Qi X, Asanuma K, Sugihara K, et al:
Endothelial PI3K-C2α, a class II PI3K, has an essential role in
angiogenesis and vascular barrier function. Net Med. 18:1560–1569.
2012. View
Article : Google Scholar
|
|
20
|
Kanungo J: Retinoic acid signaling in P19
stem cell differentiation. Anticancer Agents Med Chem.
17:1184–1198. 2017. View Article : Google Scholar
|
|
21
|
Wang L, Song G, Liu M, Chen B, Chen Y,
Shen Y, Zhu J and Zhou X: MicroRNA-375 overexpression influences
P19 cell proliferation, apoptosis and differentiation through the
notch signaling pathway. Int J Mol Med. 37:47–55. 2016. View Article : Google Scholar
|
|
22
|
McBurney MW, Jones-Villeneuve EM, Edwards
MK and Anderson PJ: Control of muscle and neuronal differentiation
in a cultured embryonal carcinoma cell line. Nature. 299:165–167.
1982. View
Article : Google Scholar
|
|
23
|
Mueller I, Kobayashi R, Nakajima T, Ishii
M and Ogawa K: Effective and steady differentiation of a clonal
derivative of P19CL6 embryonal carcinoma cell line into beating
cardiomyocytes. J Biomed Biotechnol. 2010:3805612010. View Article : Google Scholar
|
|
24
|
Song G, Shen Y, Ruan Z, Li X, Chen Y, Yuan
W, Ding X, Zhu L and Qian L: LncRNA-uc 167 influences cell
proliferation, apoptosis and differentiation of P19 cells by
regulating Mef2c. Gene. 590:97–108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
van der Heyden MA and Defize LH: Twenty
one years of P19 cells: What an embryonal carcinoma cell line
taught us about cardiomyocyte differentiation. Cardiovasc Res.
58:292–302. 2003. View Article : Google Scholar
|
|
26
|
Mcburney MW: P19 embryonal carcinoma
cells. Int J Dev Biol. 37:135–140. 1993.
|
|
27
|
Ai F, Zhang Y and Peng B: miR-20a
regulates proliferation, differentiation and apoptosis in P19 cell
model of cardiac differentiation by targeting smoothened. Biol
Open. 5:1260–1265. 2016. View Article : Google Scholar
|
|
28
|
Wang D, Liu C, Wang Y, Wang W, Wang K, Wu
X, Li Z, Zhao C, Li L and Peng L: Impact of miR-26b on
cardiomyocyte differentiation in P19 cells through regulating
canonical/non-canonical wnt signaling. Cell Proliferation.
50:e123712017. View Article : Google Scholar
|
|
29
|
Li H, Jiang L, Yu Z, Han S, Liu X, Li M,
Zhu C, Qiao L and Huang L: The role of a novel long noncoding RNA
TUC40- in cardiomyocyte induction and maturation in P19 cells. Am J
Med Sci. 354:608–616. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Van Poucke M, Van Zeveren A and Peelman
LJ: [Letter to the editor] Combined FAM-labeled TaqMan probe
detection and SYBR green I melting curve analysis in multiprobe
qPCR genotyping assays. Biotechniques. 52:81–86. 2012. View Article : Google Scholar
|
|
31
|
Wang J, Meng X, Dobrovolskaya OB, Orlov YL
and Chen M: Non-coding RNAs and their roles in stress response in
plants. Genomics Proteomics Bioinformatics. 15:301–312. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
33
|
Grossi I, Salvi A, Abeni E, Marchina E and
De Petro G: Biological function of MicroRNA193a-3p in health and
disease. Int J Genomics. 2017:59131952017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kumar V, Khare T, Shriram V and Wani SH:
Plant small RNAs: The essential epigenetic regulators of gene
expression for salt-stress responses and tolerance. Plant Cell Rep.
37:61–75. 2018. View Article : Google Scholar
|
|
35
|
Chen C, Ponnusamy M, Liu C, Gao J, Wang K
and Li P: MicroRNA as a therapeutic target in cardiac remodeling.
Biomed Res Int. 2017:12784362017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wojciechowska A, Braniewska A and
Kozar-Kamińska K: MicroRNA in cardiovascular biology and disease.
Adv Clin Exp Med. 26:865–874. 2017. View Article : Google Scholar
|
|
37
|
Sun W, Zhao L, Song X, Zhang J, Xing Y,
Liu N, Yan Y, Li Z, Lu Y, Wu J, et al: MicroRNA-210 modulates the
cellular energy metabolism shift during H2O2-induced oxidative
stress by repressing ISCU in H9c2 cardiomyocytes. Cell Physiol
Biochem. 43:383–394. 2017. View Article : Google Scholar
|
|
38
|
Chu D, Zhao Z, Li Y, Li J, Zheng J, Wang
W, Zhao Q and Ji G: Increased microRNA-630 expression in gastric
cancer is associated with poor overall survival. PLoS One.
9:e905262014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Qiao P, Li G, Bi W, Yang L, Yao L and Wu
D: microRNA-34a inhibits epithelial mesenchymal transition in human
cholangio-carcinoma by targeting Smad4 through transforming growth
factor-beta/Smad pathway. BMC Cancer. 15:4692015. View Article : Google Scholar
|
|
40
|
Rijlaarsdam MA and Looijenga LH: An
oncofetal and developmental perspective on testicular germ cell
cancer. Semin Cancer Biol. 29:59–74. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Paraskevas G, Koutsouflianiotis K and
Iliou K: The first descriptions of various anatomical structures
and embryological remnants of the heart: A systematic overview. Int
J Cardiol. 227:674–690. 2017. View Article : Google Scholar
|
|
42
|
Gittenbergerde Groot AC, Bartelings MM,
Poelmann RE, Haak MC and Jongbloed MR: Embryology of the heart and
its impact on understanding fetal and neonatal heart disease. Semin
Fetal Neonatal Med. 18:237–244. 2013. View Article : Google Scholar
|
|
43
|
Abu-Elmagd M and Wheeler G: Frizzled-7
expression during early cardiogenesis of Xenopus laevis embryo. BMC
Genomics. 15:1–2. 2014. View Article : Google Scholar
|
|
44
|
Vitagliano O, Addeo R, D’Angelo V, Indolfi
C, Indolfi P and Casale F: The Bcl-2/Bax and Ras/Raf/MEK/ERK
signaling pathways: Implications in pediatric leukemia pathogenesis
and new prospects for therapeutic approaches. Expert Rev Hematol.
6:587–597. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Siddiqui WA, Ahad A and Ahsan H: The
mystery of BCL2 family: Bcl-2 proteins and apoptosis: An update.
Arch Toxicol. 89:289–317. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Reed JC: Proapoptotic multidomain
Bcl-2/Bax-family proteins: Mechanisms, physiological roles, and
therapeutic opportunities. Cell Death Differ. 13:1378–1386. 2006.
View Article : Google Scholar : PubMed/NCBI
|
